Jun Li1, Hannah K Weir, Melissa A Jim, Sallyann M King, Reda Wilson, Viraj A Master. 1. Jun Li, Hannah K. Weir, Melissa A. Jim, and Reda Wilson are with the Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Sallyann M. King is with the Division of Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, CDC. Viraj A. Master is with the Department of Urology and Winship Cancer Institute, School of Medicine, Emory University, Atlanta.
Abstract
OBJECTIVES: We describe rates and trends in kidney cancer incidence and mortality and identify disparities between American Indian/Alaska Native (AI/AN) and White populations. METHODS: To improve identification of AI/AN race, incidence and mortality data were linked with Indian Health Service (IHS) patient records. Analysis focused on residents of IHS Contract Health Service Delivery Area counties; Hispanics were excluded. We calculated age-adjusted kidney cancer incidence (2001-2009) and death rates (1990-2009) by sex, age, and IHS region. RESULTS: AI/AN persons have a 1.6 times higher kidney cancer incidence and a 1.9 times higher kidney cancer death rate than Whites. Despite a significant decline in kidney cancer death rates for Whites (annual percentage change [APC] = -0.3; 95% confidence interval [CI] = -0.5, 0.0), death rates for AI/AN persons remained stable (APC = 0.4; 95% CI = -0.7, 1.5). Kidney cancer incidence rates rose more rapidly for AI/AN persons (APC = 3.5; 95% CI = 1.2, 5.8) than for Whites (APC = 2.1; 95% CI = 1.4, 2.8). CONCLUSIONS: AI/AN individuals have greater risk of developing and dying of kidney cancers. Incidence rates have increased faster in AI/AN populations than in Whites. Death rates have decreased slightly in Whites but remained stable in AI/AN populations. Racial disparities in kidney cancer are widening.
OBJECTIVES: We describe rates and trends in kidney cancer incidence and mortality and identify disparities between American Indian/Alaska Native (AI/AN) and White populations. METHODS: To improve identification of AI/AN race, incidence and mortality data were linked with Indian Health Service (IHS) patient records. Analysis focused on residents of IHS Contract Health Service Delivery Area counties; Hispanics were excluded. We calculated age-adjusted kidney cancer incidence (2001-2009) and death rates (1990-2009) by sex, age, and IHS region. RESULTS: AI/AN persons have a 1.6 times higher kidney cancer incidence and a 1.9 times higher kidney cancer death rate than Whites. Despite a significant decline in kidney cancer death rates for Whites (annual percentage change [APC] = -0.3; 95% confidence interval [CI] = -0.5, 0.0), death rates for AI/AN persons remained stable (APC = 0.4; 95% CI = -0.7, 1.5). Kidney cancer incidence rates rose more rapidly for AI/AN persons (APC = 3.5; 95% CI = 1.2, 5.8) than for Whites (APC = 2.1; 95% CI = 1.4, 2.8). CONCLUSIONS: AI/AN individuals have greater risk of developing and dying of kidney cancers. Incidence rates have increased faster in AI/AN populations than in Whites. Death rates have decreased slightly in Whites but remained stable in AI/AN populations. Racial disparities in kidney cancer are widening.
Authors: Thomas M Becker; James Bettles; Jodi Lapidus; Joseph Campo; Christopher J Johnson; Donald Shipley; L D Robertson Journal: Am J Public Health Date: 2002-09 Impact factor: 9.308
Authors: B A Broussard; A Johnson; J H Himes; M Story; R Fichtner; F Hauck; K Bachman-Carter; J Hayes; K Frohlich; N Gray Journal: Am J Clin Nutr Date: 1991-06 Impact factor: 7.045
Authors: Kevin R Vincent; Heather K Vincent; Randy W Braith; Shannon L Lennon; David T Lowenthal Journal: Eur J Appl Physiol Date: 2002-06-06 Impact factor: 3.078
Authors: Mary C White; David K Espey; Judith Swan; Charles L Wiggins; Christie Eheman; Judith S Kaur Journal: Am J Public Health Date: 2014-04-22 Impact factor: 9.308
Authors: Rodney C Haring; Melissa A Jim; Deborah Erwin; Judith Kaur; Whitney Ann E Henry; Marissa L Haring; Dean S Seneca Journal: Cancer Health Disparities Date: 2018-06-29
Authors: Stephanie C Melkonian; Melissa A Jim; Donald Haverkamp; Charles L Wiggins; Jeffrey McCollum; Mary C White; Judith S Kaur; David K Espey Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-10 Impact factor: 4.254
Authors: E C L Wong; R H Breau; R Mallick; L Wood; F Pouliot; N S Basappa; S Tanguay; D Soulières; A So; D Heng; L T Lavallée; D Drachenberg; A Kapoor Journal: Curr Oncol Date: 2019-06-01 Impact factor: 3.677
Authors: Elise Assouad; Said El Hage; Steven Safi; Antonio El Kareh; Elie Mokled; Pascale Salameh Journal: Cancer Causes Control Date: 2021-11-28 Impact factor: 2.506
Authors: Ken Batai; Alfredo Harb-De la Rosa; Aye Lwin; Fahad Chaus; Francine C Gachupin; Elinora Price; Benjamin R Lee Journal: Clin Genitourin Cancer Date: 2018-10-27 Impact factor: 2.872
Authors: Bridget M Cavanagh; Claire E Wakefield; Jordana K McLoone; Gail Garvey; Richard J Cohn Journal: J Cancer Surviv Date: 2015-09-07 Impact factor: 4.442
Authors: Dorothy A Rhoades; John Farley; Stephen M Schwartz; Kimberly M Malloy; Wenyu Wang; Lyle G Best; Ying Zhang; Tauqeer Ali; Fawn Yeh; Everett R Rhoades; Elisa Lee; Barbara V Howard Journal: Cancer Epidemiol Date: 2021-07-19 Impact factor: 2.890